1. Home
  2. CERS vs WNC Comparison

CERS vs WNC Comparison

Compare CERS & WNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERS
  • WNC
  • Stock Information
  • Founded
  • CERS 1991
  • WNC 1985
  • Country
  • CERS United States
  • WNC United States
  • Employees
  • CERS N/A
  • WNC N/A
  • Industry
  • CERS EDP Services
  • WNC Construction/Ag Equipment/Trucks
  • Sector
  • CERS Technology
  • WNC Industrials
  • Exchange
  • CERS Nasdaq
  • WNC Nasdaq
  • Market Cap
  • CERS 276.0M
  • WNC 307.1M
  • IPO Year
  • CERS 1997
  • WNC 1991
  • Fundamental
  • Price
  • CERS $1.69
  • WNC $8.25
  • Analyst Decision
  • CERS Buy
  • WNC Hold
  • Analyst Count
  • CERS 1
  • WNC 1
  • Target Price
  • CERS $4.00
  • WNC $9.00
  • AVG Volume (30 Days)
  • CERS 1.3M
  • WNC 521.5K
  • Earning Date
  • CERS 11-06-2025
  • WNC 10-30-2025
  • Dividend Yield
  • CERS N/A
  • WNC 3.85%
  • EPS Growth
  • CERS N/A
  • WNC N/A
  • EPS
  • CERS N/A
  • WNC 6.15
  • Revenue
  • CERS $199,191,000.00
  • WNC $1,638,115,000.00
  • Revenue This Year
  • CERS $19.07
  • WNC N/A
  • Revenue Next Year
  • CERS $12.03
  • WNC $14.72
  • P/E Ratio
  • CERS N/A
  • WNC $1.35
  • Revenue Growth
  • CERS 13.03
  • WNC N/A
  • 52 Week Low
  • CERS $1.12
  • WNC $6.78
  • 52 Week High
  • CERS $2.24
  • WNC $20.63
  • Technical
  • Relative Strength Index (RSI)
  • CERS 59.26
  • WNC 50.63
  • Support Level
  • CERS $1.47
  • WNC $7.64
  • Resistance Level
  • CERS $1.78
  • WNC $8.38
  • Average True Range (ATR)
  • CERS 0.13
  • WNC 0.31
  • MACD
  • CERS 0.01
  • WNC 0.12
  • Stochastic Oscillator
  • CERS 78.75
  • WNC 84.09

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

About WNC Wabash National Corporation

Wabash National Corp operates as the innovation leader of connected solutions for the transportation, logistics, and distribution industries. The Company manages its business in two operating and reportable segments: Transportation Solutions and Parts & Services. It designs and manufactures products including dry freight and refrigerated trailers, platform trailers, tank trailers, dry and refrigerated truck bodies, structural composite panels and products, trailer aerodynamic solutions, and specialty food-grade processing equipment.

Share on Social Networks: